CA
NZ
UK
AU
IND
US
GAAP grossMarginwas 47.5%, and non-GAAP gross margin was 48.5%, versus 37.5% on a non-GAAP basis a year earlier. Management credited higherVolumeand a better product mix. Consumables, including WaferPak contactors and burn-in modules, brought in $13.5 million, or 41% of revenue, compared with $2.6 million, …
FFO was $15.2 million, or $0.16 per diluted share, versus $20.2 million, or $0.20. FFO as adjusted was $15.3 million, or $0.16, compared with $17.0 million, or $0.17, reflecting lower termination fees and higherStock Compensationand technology costs. TotalRevenuewas $52.3 million versus $53.1 million, about …
The gap to adjusted results came mainly from $33.3 million of net pre-tax charges for the sale and wind-down of several businesses and product lines, which the company said it substantially completed in the quarter. The charges covered inventory write-downs, asset impairments and wind-down …
Alexander's is a real estateInvestmenttrust that leases, manages, develops and redevelops four New York City properties totaling about 2.1 million square feet. An affiliated REIT manages it and handles leasing and development under fee arrangements.
Allison designs and makes fully automatic transmissions and drive systems for commercial vehicles, buses, defense and industrial uses. North America On-Highway sales hit a record $462 million, up 41%, on strongerDemandfor medium-duty and Class 8 vocational trucks. Management said fleets are aged, it sees …
Net income was $30.7 billion, up from $27.5 billion, andDiluted Earnings per Shareof $2.10 compared with $1.85 a year ago. Management saidNet Incomeand EPS set September quarter records even without the tariff refund benefit.
Atlas supplies frac sand and logistics to oil and gas producers in the PermianBasinand is building a private-grid powerBusinessfor customers withoutUtilityaccess. Its CEO said the company chose to hold pricing rather than chase uneconomic bids, which reduced third quarter volumes.
Axsome is a New York biopharmaceutical company that markets treatments for central nervous system conditions. Auvelity, approved for major depressive disorder and, since June 2026, for agitation associated with Alzheimer's disease, produced $207.6 million of sales, up from $136.1 million.
Backblaze provides cloud storage through its B2 Cloud Storage service and Computer Backup product, and describes itself as the capacity storage layer for AI. B2 revenue grew from $20.7 million to $30.5 million, accelerating from 34% growth in the second quarter. A May 1 …
Metabolic Conditions revenue rose 44% to $744 million. GALAFOLD contributed $152 million and POMBILITI plus OPFOLDA added $49 million in their first full quarter after the AmicusAcquisitionclosed on Apr 27, 2026. VIMIZIM grew 18% to $216 million, while NAGLAZYME fell 11% to $108 million …
Please wait processing your request...